- Home
- SYRE vs NBN Comparison
SYRE vs NBN Comparison
Compare SYRE & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- NBN
- Stock Information
- Founded
- SYRE 2013
- NBN 1872
- Country
- SYRE United States
- NBN United States
- Employees
- SYRE N/A
- NBN N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- NBN Major Banks
- Sector
- SYRE Health Care
- NBN Finance
- Exchange
- SYRE Nasdaq
- NBN Nasdaq
- Market Cap
- SYRE 841.4M
- NBN 766.7M
- IPO Year
- SYRE 2016
- NBN N/A
- Fundamental
- Price
- SYRE $15.72
- NBN $96.11
- Analyst Decision
- SYRE Buy
- NBN Buy
- Analyst Count
- SYRE 6
- NBN 2
- Target Price
- SYRE $55.00
- NBN $97.50
- AVG Volume (30 Days)
- SYRE 673.0K
- NBN 115.0K
- Earning Date
- SYRE 08-06-2025
- NBN 07-28-2025
- Dividend Yield
- SYRE N/A
- NBN 0.04%
- EPS Growth
- SYRE N/A
- NBN 23.53
- EPS
- SYRE N/A
- NBN 8.99
- Revenue
- SYRE N/A
- NBN $184,337,000.00
- Revenue This Year
- SYRE N/A
- NBN $36.62
- Revenue Next Year
- SYRE N/A
- NBN $11.46
- P/E Ratio
- SYRE N/A
- NBN $10.76
- Revenue Growth
- SYRE N/A
- NBN 24.54
- 52 Week Low
- SYRE $10.91
- NBN $61.74
- 52 Week High
- SYRE $40.26
- NBN $110.35
- Technical
- Relative Strength Index (RSI)
- SYRE 51.34
- NBN 69.77
- Support Level
- SYRE $14.97
- NBN $94.13
- Resistance Level
- SYRE $16.92
- NBN $97.26
- Average True Range (ATR)
- SYRE 1.12
- NBN 2.42
- MACD
- SYRE 0.02
- NBN 0.89
- Stochastic Oscillator
- SYRE 58.05
- NBN 92.20
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.